Gloria Bonaccorsi

Gloria Bonaccorsi

Auto-generated profile, based on publicly available information

Gloria Bonaccorsi

Department of Translational Medicine, Menopause and Osteoporosis Center, University of Ferrara, Ferrara, Italy

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
PGPantaleo Greco
Pantaleo Greco
GNG. Nencini
G. Nencini
IPI. Piva
I. Piva
Marco SciosciaMarco Scioscia
Marco Scioscia
CVCarlo Alberto Volta
Carlo Alberto Volta
LNLuigi Nappi
Luigi Nappi

Verified
Journal Article
Open access
PDF file
Donato GemmatiDonato Gemmati
Donato Gemmati
Katia VaraniKatia Varani
Katia Varani
BBBarbara Bramanti
Barbara Bramanti
RPRoberta Piva
Roberta Piva
GBGloria Bonaccorsi
Gloria Bonaccorsi
Tiziana BelliniTiziana Bellini
Tiziana Bellini
Gender medicine is the first step of personalized medicine and patient-centred care, an essential development to achieve the standard goal of a holistic approach to patients and diseases. By addressing the interrelation and integration of biological markers (i.e., sex) with indicators of psychological/cultural behaviour (i.e., gender), gender medicine represents the crucial assumption for achieving the personalized health-care required in the third millennium. However, ‘sex’ and ‘gender’ are often misused as synonyms, leading to frequent misunderstandings in those who are not deeply involved in the field. Overall, we have to face the evidence that biological, genetic, epigenetic, psycho-social, cultural, and environmental factors mutually interact in defining sex/gender differences, and at the same time in establishing potential unwanted sex/gender disparities. Prioritizing the role of sex/gender in physiological and pathological processes is crucial in terms of efficient prevention, clinical signs’ identification, prognosis definition, and therapy optimization. In this regard, the omics-approach has become a powerful tool to identify sex/gender-specific disease markers, with potential benefits also in terms of socio-psychological wellbeing for each individual, and cost-effectiveness for National Healthcare systems. “Being a male or being a female” is indeed important from a health point of view and it is no longer possible to avoid “sex and gender lens” when approaching patients. Accordingly, personalized healthcare must be based on evidence from targeted research studies aimed at understanding how sex and gender influence health across the entire life span. The rapid development of genetic tools in the molecular medicine approaches and their impact in healthcare is an example of highly specialized applications that have moved from specialists to primary care providers (e.g., pharmacogenetic and pharmacogenomic applications in routine medical practice). Gender medicine needs to follow the same path and become an established medical approach. To face the genetic, molecular and pharmacological bases of the existing sex/gender gap by means of omics approaches will pave the way to the discovery and identification of novel drug-targets/therapeutic protocols, personalized laboratory tests and diagnostic procedures (sex/gender-omics). In this scenario, the aim of the present review is not to simply resume the state-of-the-art in the field, rather an opportunity to gain insights into gender medicine, spanning from molecular up to social and psychological stances. The description and critical discussion of some key selected multidisciplinary topics considered as paradigmatic of sex/gender differences and sex/gender inequalities will allow to draft and design strategies useful to fill the existing gap and move forward.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Carlo CervellatiCarlo Cervellati
Carlo Cervellati
GBGloria Bonaccorsi
Gloria Bonaccorsi
ECEleonora Cremonini
Eleonora Cremonini
ARArianna Romani
Arianna Romani
EFEnrica Fila
Enrica Fila
LMLeo Massari
Leo Massari
The underlying mechanism in postmenopausal osteoporosis (PO) is an imbalance between bone resorption and formation. This study was conducted to investigate whether oxidative stress (OxS) might have a role in this derangement of bone homeostasis. In a sample of 167 postmenopausal women, we found that increased serum levels of a lipid peroxidation marker, hydroperoxides, were negatively and independently associated with decreasedbone mineral density(BMD) in total body (r=-0.192,P<0.05), lumbar spine (r=-0.282,P<0.01), and total hip (r=-0.282,P<0.05), as well as with increased bone resorption rate (r=0.233,P<0.05), as assessed by the serum concentration of C-terminal telopeptide of type I collagen (CTX-1). On the contrary, the OxS marker failed to be correlated with the serum levels of bone-specific alkaline phosphatase (BAP), that is, elective marker of bone formation. Importantly, multiple regression analysis revealed that hydroperoxides is a determinant factor for the statistical association between lumbar spine BMD and CTX-1 levels. Taken together, our data suggest that OxS might mediate, by enhancing bone resorption, the uncoupling of bone turnover that underlies PO development.

23 May 2012 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
Carlo CervellatiCarlo Cervellati
Carlo Cervellati
GBGloria Bonaccorsi
Gloria Bonaccorsi
ECEleonora Cremonini
Eleonora Cremonini
Carlo M. BergaminiCarlo M. Bergamini
Carlo M. Bergamini
APAlfredo Patella
Alfredo Patella
LMLeo Massari
Leo Massari
Background: Post-menopausal osteoporosis (PO) affecting a large fraction of elderly women, is triggered by the decline in 17β-estradiol (E2) level. Experimental studies in animal models and cell cultures have suggested that the fall in E2 might contribute to developing oxidative stress (OS) which in turn is believed to play an important role in PO pathogenesis. The scarcity of human studies focusing on this issue prompted us to investigate the effects of the reproductive and post-reproductive phase of women’s life on OS and bone health. Methods: Serum parameters of oxidative challenge (lipid hydroperoxides and protein advanced oxidation products) and antioxidant defence (total serum antioxidants levels) along with bone mineral density (BMD) at femoral neck and lumbar spine were assessed in a sample of 191 women (98 pre- and 93 post-menopausal, of whom 30 osteoporotic). Results: Pearson’s correlation analysis unveiled that spinal BMD was negatively correlated with lipid hydroperoxides in overall postmenopausal subsample (r=–0.251, p=0.012), while no significant link between these two variables was detected in women in reproductive age (r=–0.022, p=0.833). Noteworthy, stepwise multiple regression analysis showed that the association found in post-menopausal women retained significance after adjusting for potential confounding factors (p=0.001). Conclusions: Our data showed that markers of oxidative challenge are associated with bone loss in women in post-menopausal status. We suggest that menopause-related estrogen withdrawal might contribute to make bone more vulnerable to oxidative injury thereby increasing the risk of PO development.

1 January 2008 in Menopause
Verified
Journal Article
Closed access
FPFrancesco Pansini
Francesco Pansini
Carlo CervellatiCarlo Cervellati
Carlo Cervellati
AGAngela Guariento
Angela Guariento
MSMaria Antonella Stacchini
Maria Antonella Stacchini
CCCristina Castaldini
Cristina Castaldini
Carlo M. BergaminiCarlo M. Bergamini
Carlo M. Bergamini
To evaluate the role of menopause on the regional composition and distribution of fat in women and eventual correlations with the oxidative state. In this observational clinical investigation, 90 women (classified for menopause status according to Stages of Reproductive Aging Workshop criteria) were evaluated for body mass composition and fat distribution by dual-energy x-ray absorptiometry and for oxidative status by determination of serum hydroperoxide levels and residual antioxidant activity. Total body fat mass increases significantly in postmenopause (P P The results of our investigation demonstrate that fat content increases in the upper part of the body (trunk and arms) in postmenopause and that age is the main determinant of this increase. During the comparison of premenopausal and postmenopausal women, we also detected a significant increase in antioxidant status. Apparently this change is mainly related to menopausal endocrine and fat changes.

1 September 2019 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
Elisabetta CaselliElisabetta Caselli
Elisabetta Caselli
ISIrene Soffritti
Irene Soffritti
MDMaria D'Accolti
Maria D'Accolti
IPIsabella Piva
Isabella Piva
PGPantaleo Greco
Pantaleo Greco
GBGloria Bonaccorsi
Gloria Bonaccorsi
Atopobium vaginae And Porphyromonas somerae Induce Proinflammatory Cytokines Expression In Endometrial Cells: A Possible Implication For Endometrial Cancer? Elisabetta Caselli,1 Irene Soffritti,1 Maria D’Accolti,1 Isabella Piva,2 Pantaleo Greco,2 Gloria Bonaccorsi2 1Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, ItalyCorrespondence: Elisabetta CaselliSection of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, ItalyTel +39 0532 455387Fax +39 0532 974470Email csb@unife.itThe female lower vaginal tract has long been known to have an active microbiota, with Lactobacilli genus representing the prevalent species, and alterations in the vaginal microbiota are known to play a role in different pathological conditions, including bacterial vaginosis, sexually transmitted diseases, HPV persistence, and cervical cancer.By contrast, the uterus was considered sterile until recently, when the advent of next-generation sequencing (NGS) technologies identified a unique uterine microbiota differing from that of the vagina.1The uterine bacterial load is estimated to be 100–10,000-times lower than that of the vaginal microbiome, and, contrary to the vaginal and cervix microbiota, uterine bacteria grow in mildly alkaline conditions, contrasting to the Lactobacillus-dominated low pH environment of the vagina.2